Ventolin Aerosol, Metered
Product Images NDC 0173-0682

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Ventolin (NDC 0173-0682). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ventolinhfa Spl Graphic 01)

Chemical Structure (Ventolinhfa Spl Graphic 01)
Chemical structure of albuterol sulfate depicted as a labeled diagram showing functional groups and bonds, including the sulfate component indicated as H2SO4.*
FDA Label Image

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial Day 1 (Ventolinhfa Spl Graphic 02)

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial Day 1 (Ventolinhfa Spl Graphic 02)
Line graph comparing mean percentage change from baseline over 6 hours for three groups: CFC 11/12-propelled albuterol (triangle), VENTOLIN HFA (circle), and HFA-134a placebo inhaler (square). The graph shows efficacy measured by changes at multiple time points, with VENTOLIN HFA showing intermediate values between the active and placebo groups.*
FDA Label Image

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial Week 12 (Ventolinhfa Spl Graphic 03)

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial Week 12 (Ventolinhfa Spl Graphic 03)
A line graph depicting the mean percent change from baseline over time (hours) for three treatments: CFC 11/12-propelled albuterol inhaler, VENTOLIN HFA inhaler, and HFA-134a placebo inhaler. The graph compares the response over 6 hours after 2 inhalations 4 times daily, showing greater effect for the albuterol inhalers versus placebo.*
FDA Label Image

Figure A (Ventolinhfa Spl Graphic 04)

Figure A (Ventolinhfa Spl Graphic 04)
An instructional diagram of a metered-dose inhaler for albuterol sulfate, showing labeled parts including a metal canister, blue plastic actuator, blue mouthpiece, blue cap, and dose counter. The inhaler components are drawn separately to clarify each part's position and function.*
FDA Label Image

Figure B (Ventolinhfa Spl Graphic 05)

Figure B (Ventolinhfa Spl Graphic 05)
An instructional illustration showing two hands holding a VENTOLIN HFA inhaler and a small component, with an arrow indicating insertion or assembly. The image demonstrates a step in preparing or using the metered-dose aerosol inhaler for respiratory inhalation.*
FDA Label Image

Figure C (Ventolinhfa Spl Graphic 06)

Figure C (Ventolinhfa Spl Graphic 06)
An instructional illustration showing proper use of an inhaler device, specifically a metered-dose aerosol inhaler. The image depicts a hand holding the inhaler with the index finger pressing down on the top actuator to release a spray. The user's mouth is positioned to inhale the medication, and the mouthpiece cover is shown removed and resting nearby.*
FDA Label Image

Figure D (Ventolinhfa Spl Graphic 07)

Figure D (Ventolinhfa Spl Graphic 07)
An instructional illustration showing a hand holding an inhaler device in a primed position with a label indicating "200" doses. This likely depicts proper handling or dose administration for an aerosol inhalation device.*
FDA Label Image

Figure E (Ventolinhfa Spl Graphic 08)

Figure E (Ventolinhfa Spl Graphic 08)
An instructional illustration showing the proper throat-down position for the VENTOLIN HFA inhaler. The image highlights the inhaler's blue mouthpiece and blue cap, with a hand holding the device vertically, displaying the dose counter reading 200.*
FDA Label Image

Figure F (Ventolinhfa Spl Graphic 09)

Figure F (Ventolinhfa Spl Graphic 09)
An instructional illustration showing a side profile of a person's face exhaling, accompanied by text that says 'Breathe out as much air as you can,' with an arrow indicating the direction of the exhaled air.*
FDA Label Image

Figure G (Ventolinhfa Spl Graphic 10)

Figure G (Ventolinhfa Spl Graphic 10)
An instructional diagram showing a person using an inhaler. The image depicts the person holding the inhaler near their mouth with the text 'Push down and breathe in' and an arrow indicating the inhaler activation motion toward the mouth.*
FDA Label Image

Figure H (Ventolinhfa Spl Graphic 11)

Figure H (Ventolinhfa Spl Graphic 11)
An instructional illustration showing correct and incorrect use of a metered-dose inhaler. The top image labeled "Not blocked" depicts the inhaler spraying aerosol properly. The bottom image labeled "Blocked" shows the inhaler's spray blocked, with no aerosol emitted.*
FDA Label Image

Figure I (Ventolinhfa Spl Graphic 12)

Figure I (Ventolinhfa Spl Graphic 12)
An instructional illustration showing a hand holding a VENTOLIN HFA metered dose inhaler under running water, demonstrating how to clean the inhaler mouthpiece. Water is flowing from a faucet, rinsing the inhaler, with water droplets depicted around the device.*
FDA Label Image

Figure J (Ventolinhfa Spl Graphic 13)

Figure J (Ventolinhfa Spl Graphic 13)
An instructional illustration showing a hand holding an inhaler canister above a holder or base under running water, indicating the cleaning of the inhaler device parts by rinsing with water.*
FDA Label Image

Figure K (Ventolinhfa Spl Graphic 14)

Figure K (Ventolinhfa Spl Graphic 14)
Illustration showing the components of a VENTOLIN HFA albuterol sulfate metered aerosol inhaler with dose counter, including the mouthpiece actuator, inhaler canister, and a protective vest-shaped case with a crescent moon symbol on it.*
FDA Label Image

Ventolin Hfa 200 Dose Label (Ventolinhfa Spl Graphic 15)

Ventolin Hfa 200 Dose Label (Ventolinhfa Spl Graphic 15)
Label for VENTOLIN HFA albuterol sulfate inhalation aerosol 90 mcg per actuation, 200 metered inhalations. The label includes usage instructions, warnings, storage conditions, and manufacturer details, GlaxoSmithKline LLC. The net weight is 18 g, and the product is made in the United Kingdom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.